Photolability of potential calcium channel antagonists: Hexahydroquinoline derivatives

Journal of Photochemistry and Photobiology A: Chemistry

Volumn 192, Issue 2-3, 2007, Pages 197-203

  Mielcarek, Jadwiga ^a   Khmelinskii, Igor ^b   Sikorski, Marek ^c   Stefaniak, Hanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF ALGARVE   (Portugal)

^c ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Calcium channel blockers; Dihydropyridine derivatives; Drugs; Photodegradation; Photostability

Indexed keywords

EID: 35348944455     PISSN: 10106030     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotochem.2007.05.024     Document Type: Article

References (28)

1. Eisenberg M.J., Brox A., and Bestawros A.N. Am. J. Med. 116 (2004) 35-43
2. Kobayashi T., and Mori Y. Eur. J. Pharmacol. 363 (1998) 1-15
3. Inzitari D., and Pogessi A. Aging Clin. Exp. Res. 17 (2005) 16-30
4. Cleophas T.J., and van Marum R. Am. J. Cardiol. 87 (2001) 487-490
5. Ilavsky D., and Milata V. Collect. Czech. Chem. Commun. 61 (1996) 1233-1243
6. Miri R., Niknahad H., Vesal G., and Shafiee A. Farmaco 57 (2002) 123-128
7. Andreani A., Leoni A., Rambaldi M., Locatelli A., Bossa R., Galatulas I., Chiericozzi M., and Bissoli M. Eur. J. Med. Chem. 32 (1997) 151-157
8. Kruk I., Kladna A., Lichszteld K., Michalska T., Boul-Enein H.Y., Tuncbilek M., and Ertan R. Biopolymers 62 (2001) 163-167
9. Nakajima M., Adachi I., and Ueda M. Arzneim.-Forsch./Drug Res. 43 (1993) 1276-1282
10. Ueda M., Matsumura S., Masui M., Matsuura E., Kawakami M., Fujitomo H., Umeda T., Kagawa H., Hirohata S., Shima K., and Adachi I. Arzneim.-Forsch./Drug Res. 43 (1993) 1282-1290
11. de Vries R.J.M., van Veldhuisen D.J., and Dunselman P.H.J.M. Am. Heart J. 139 (2000) 185-194
12. Yamamoto T., Niwa S., Ohno S., Onishi T., Matsueda H., Koganei H., Uneyama H., Fujita S.I., Takeda T., Kito M., Ono Y., Saitou Y., Takahara A., Iwata S., and Shoji M. Bioorg. Med. Chem. Lett. 16 (2006) 798-802
13. Aydin F., Safak C., Simsek R., Erol K., Ulgen M., and Linden A. Pharmazie 61 (2006) 655-659
14. Kismetli E., Safak C., Erol K., Sirmagül B., and Linden A. Arzneim.-Forsch./Drug Res. 54 (2004) 371-375
15. Simsek R., Safak C., Erol K., and Sirmagül B. Arzneim.-Forsch./Drug Res. 51 (2001) 959-963
16. Simsek R., Safak C., Erol K., and Sirmagül B. Pharmazie 56 (2001) 665-666
17. Simsek R., Ismailoglu U.B., Safak C., and Sahin-Erdemli I. Farmaco 55 (2000) 665-668
18. Simsek R., Safak C., Erol K., Ataman S., Ulgen M., and Linden A. Arzneim.-Forsch./Drug Res. 53 (2003) 159-166
19. Beijersbergen van Henegouwen G.M.J. Medicinal Photochemistry: Phototoxic and Phototherapeutic Aspects of Drugs, Advances in Drug Research (1997), Academic Press, New York
20. Aman W., and Thoma K. Pharmazie 58 (2003) 877-880
21. Mielcarek J., Augustyniak W., Grobelny P., and Nowacka G. Int. J. Pharm. 304 (2005) 145-151
22. Mielcarek J., Safak C., Simsek R., and Matloka A. Arch. Pharm. 335 (2002) 77-82
23. Drew H.D. Photostability of Drug Substances and Drug Products: A Validated Reference Method for Implementing the ICH Photostability Study Guidelines. In: Albini A., and Fasani E. (Eds). Drugs Photochemistry and Photostability (1998), The Royal Society of Chemistry, Cambridge 227-242
24. Favaro G. Actinometry: Concepts and Experiments. In: Albini A., and Fasani E. (Eds). Drugs Photochemistry and Photostability (1998), The Royal Society of Chemistry, Cambridge 296-304
25. Augustyniak W., Mielcarek J., Milewski M., and Szamburska O. Drug Dev. Ind. Pharm. 27 (2001) 1031-1038
26. Mielcarek J. J. Pharm. Biomed. Anal. 15 (1997) 681-686
27. Baranda A.B., Mueller C.A., Alonso R.M., Jimenez R.M., and Weinmann W. Ther. Drug Monit. 27 (2005) 44-52
28. Barbato F., Grumetto L., and Morrica P. Farmaco 49 (1994) 461-466